Ibrutinib improves survival in CLL and SLL patients: Results From the RESONATE …

Milan, June 13, 2014 - On Behalf of the RESONATE Investigators, Dr Hillmen will present the results from the Phase III trial in CLL and SLL patients.

Read more

ABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial acti…

Milan, June 13, 2014 – Promising results from phase-I study for CLL patients will be presented by Dr John Seymour.

Milan, June 13, 2014 – Promising results from phase-I study for CLL patients will be
presented by Dr John SeymourMilan, June 13, 2014 – Promising results from phase-I study or CLL patients will be presented by D
Read more

Do generics of imatinib jeopardize patient safety for the sake of saving money? …

Milan, June 13, 2014 – Dr Zafer Başlar will present the results of a multicenter study that was conducted in Turkey to evaluate the efficacy and tolerability of generics for CML patients.

Read more

Treatment of acute lymphoblastic leukemia by activation of patient's immune cell…

Milan, June 13, 2014 – Dr Nicola Gökbuget will explain also on behalf of Max Topp, the results of two abstracts that will be presented during the 19th Congress of EHA about the treatment of ALL.

Read more

Gdf -11 a new target to improve anemia in thalassemia.

Milan, June 13, 2014 – New possible treatment options for thalassemia patients will be presented by Dr Olivier Hermine at the 19th Congress of EHA.

Read more

Can Eltrombopag help children with ITP say goodbye to bleeding?

Milan, June 13, 2014 – Results from a large international study on pediatric ITP will be presented at the 19th Congress of EHA by Dr John Grainger.

Read more

Pivotal Ruxolitinib Data Shows Promise for Patients with PV.

Milan, June 13, 2014 – Dr Alessandro Vannucchi will present the promising results of a Phase III trial for polycythemia vera patients.

Read more